Professional Documents
Culture Documents
DR Reddy's Labs
DR Reddy's Labs
DR Reddy's Labs
IN
Narration Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Trailing Best Case Worst Case
Sales 7,435.20 9,814.50 11,832.60 13,415.30 15,023.30 15,568.30 14,196.10 14,281.00 15,448.20 17,517.00 18,183.40 19,862.85 18,084.15
Expenses 5,874.30 7,389.80 9,167.30 10,164.50 11,529.70 11,983.00 11,723.90 11,929.80 12,270.00 15,039.90 15,245.50 16,496.83 15,162.28
Operating Profit 1,560.90 2,424.70 2,665.30 3,250.80 3,493.60 3,585.30 2,472.20 2,351.20 3,178.20 2,477.10 2,937.90 3,366.03 2,921.86
Other Income 52.30 11.90 149.90 169.70 274.10 295.00 171.50 155.20 381.30 670.00 322.30 - -
Depreciation 398.10 518.10 550.20 647.50 759.90 938.90 1,026.60 1,077.20 1,134.80 1,163.10 1,169.80 1,169.80 1,169.80
Interest 32.30 114.10 100.30 126.70 108.20 82.60 63.40 78.80 88.90 98.30 86.70 86.70 86.70
Profit before tax 1,182.80 1,804.40 2,164.70 2,646.30 2,899.60 2,858.80 1,553.70 1,350.40 2,335.80 1,885.70 2,003.70 2,109.53 1,665.36
Tax 183.90 503.50 637.90 683.10 563.20 751.10 296.50 438.00 385.80 -140.30 394.60 20% 20%
Net profit 998.90 1,300.90 1,526.80 1,963.20 2,336.40 2,130.60 1,292.10 946.80 1,950.00 2,026.00 1,609.10 1,694.08 1,337.39
EPS 59.04 76.70 89.92 115.41 137.11 124.89 77.98 57.07 117.40 121.90 96.77 101.88 80.43
Price to earning 27.76 23.01 19.65 22.21 25.44 24.30 33.76 36.46 23.68 25.60 50.52 50.52 28.40
Price 1,639.05 1,764.75 1,766.50 2,563.90 3,488.75 3,035.20 2,632.35 2,080.55 2,780.25 3,120.75 4,888.65 5,146.84 2,284.11
RATIOS:
Dividend Payout 19.06% 17.93% 16.68% 15.61% 14.59% 16.01% 25.66% 35.07% 17.03% 20.51%
OPM 20.99% 24.71% 22.53% 24.23% 23.25% 23.03% 17.41% 16.46% 20.57% 14.14% 16.16%
Narration Jun-18 Sep-18 Dec-18 Mar-19 Jun-19 Sep-19 Dec-19 Mar-20 Jun-20 Sep-20
Sales 3,736.50 3,817.50 3,864.60 4,029.60 3,858.20 4,812.80 4,397.10 4,448.90 4,426.50 4,910.90
Expenses 2,967.70 3,058.20 3,060.00 3,210.70 3,116.50 3,749.00 4,685.80 3,499.70 3,305.20 3,754.80
Operating Profit 768.80 759.30 804.60 818.90 741.70 1,063.80 -288.70 949.20 1,121.30 1,156.10
Other Income 58.70 139.10 111.20 99.00 446.40 65.70 84.90 84.10 94.80 58.50
Depreciation 278.70 278.60 290.30 287.20 289.00 313.10 286.90 274.10 292.30 316.50
Interest 19.50 20.80 24.10 24.50 29.80 30.30 15.20 23.00 23.30 25.20
Profit before tax 529.30 599.00 601.40 606.20 869.30 786.10 -505.90 736.20 900.50 872.90
Tax 53.20 80.70 101.10 150.80 192.80 -320.70 32.50 -44.90 305.90 101.10
Net profit 476.10 518.30 500.30 455.40 676.50 1,106.80 -538.40 781.10 594.60 771.80
OPM 21% 20% 21% 20% 19% 22% -7% 21% 25% 24%
DR REDDY'S LABORATORIES LTD SCREENER.IN
Narration Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Equity Share Capital 84.60 84.80 84.90 85.10 85.20 85.30 82.90 83.00 83.00 83.10
Reserves 3,947.30 4,904.20 6,284.20 7,780.10 9,767.90 12,484.50 12,179.20 12,488.60 13,994.10 15,616.30
Borrowings 2,370.70 3,233.90 3,682.20 4,477.00 4,314.10 3,352.10 4,918.50 5,071.40 3,838.10 2,210.20
Other Liabilities 2,460.60 3,082.20 3,328.90 3,563.30 4,289.90 4,408.50 4,473.90 4,706.30 4,503.10 5,313.70
Total 8,863.20 11,305.10 13,380.20 15,905.50 18,457.10 20,330.40 21,654.50 22,349.30 22,418.30 23,223.30
Net Block 3,385.50 3,411.70 4,050.60 4,640.80 5,377.00 6,563.00 6,930.70 6,968.00 7,191.00 6,850.30
Capital Work in Progress 575.20 708.50 565.30 638.80 529.00 772.20 3,324.50 3,470.50 2,933.50 1,535.10
Investments 0.90 207.90 197.00 1,066.80 2,247.80 3,833.10 2,109.70 2,298.30 2,587.10 2,677.80
Other Assets 4,901.60 6,977.00 8,567.30 9,559.10 10,303.30 9,162.10 9,289.60 9,612.50 9,706.70 12,160.10
Total 8,863.20 11,305.10 13,380.20 15,905.50 18,457.10 20,330.40 21,654.50 22,349.30 22,418.30 23,223.30
Working Capital 2,441.00 3,894.80 5,238.40 5,995.80 6,013.40 4,753.60 4,815.70 4,906.20 5,203.60 6,846.40
Debtors 1,761.10 2,536.80 3,180.40 3,325.30 4,101.20 4,125.00 3,798.60 4,052.70 3,986.90 5,027.80
Inventory 1,599.20 1,943.30 2,170.70 2,418.80 2,569.90 2,557.90 2,852.80 2,908.90 3,357.90 3,506.70
Debtor Days 86.45 94.34 98.11 90.47 99.64 96.71 97.67 103.58 94.20 104.76
Inventory Turnover 4.65 5.05 5.45 5.55 5.85 6.09 4.98 4.91 4.60 5.00
Return on Equity 25% 26% 24% 25% 24% 17% 11% 8% 14% 13%
Return on Capital Emp 26% 25% 25% 23% 20% 10% 8% 14% 11%
DR REDDY'S LABORATORIES LTD SCREENER.IN
Narration Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20
Cash from Operating Activity 755.40 1,612.60 1,377.90 1,969.70 2,523.50 3,262.60 2,144.40 1,803.00 2,870.40 2,984.10
Cash from Investing Activity -884.80 -970.70 -1,436.90 -1,603.50 -2,369.80 -1,609.90 -1,889.60 -1,482.60 -769.20 -494.80
Cash from Financing Activity 44.50 389.10 -156.80 -24.20 -433.20 -1,700.10 -369.10 -444.00 -2,132.60 -2,515.90
Net Cash Flow -84.90 1,031.00 -215.80 342.00 -279.50 -47.40 -114.30 -123.60 -31.40 -26.60
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.
TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
s… do ANYTHING.
@dalal-street.in
COMPANY NAME DR REDDY'S LABORATORIES LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10
META
Number of shares 16.63
Face Value 5.00
Current Price 4,888.65
Market Capitalization 81,291.01
Quarters
Report Date Jun-18 Sep-18 Dec-18 Mar-19
Sales 3,736.50 3,817.50 3,864.60 4,029.60
Expenses 2,967.70 3,058.20 3,060.00 3,210.70
Other Income 58.70 139.10 111.20 99.00
Depreciation 278.70 278.60 290.30 287.20
Interest 19.50 20.80 24.10 24.50
Profit before tax 529.30 599.00 601.40 606.20
Tax 53.20 80.70 101.10 150.80
Net profit 476.10 518.30 500.30 455.40
Operating Profit 768.80 759.30 804.60 818.90
BALANCE SHEET
Report Date Mar-11 Mar-12 Mar-13 Mar-14
Equity Share Capital 84.60 84.80 84.90 85.10
Reserves 3,947.30 4,904.20 6,284.20 7,780.10
Borrowings 2,370.70 3,233.90 3,682.20 4,477.00
Other Liabilities 2,460.60 3,082.20 3,328.90 3,563.30
Total 8,863.20 11,305.10 13,380.20 15,905.50
Net Block 3,385.50 3,411.70 4,050.60 4,640.80
Capital Work in Progress 575.20 708.50 565.30 638.80
Investments 0.90 207.90 197.00 1,066.80
Other Assets 4,901.60 6,977.00 8,567.30 9,559.10
Total 8,863.20 11,305.10 13,380.20 15,905.50
Receivables 1,761.10 2,536.80 3,180.40 3,325.30
Inventory 1,599.20 1,943.30 2,170.70 2,418.80
Cash & Bank 575.10 1,606.10 2,017.10 2,300.60
No. of Equity Shares ### ### ### ###
New Bonus Shares
Face value 5.00 5.00 5.00 5.00
CASH FLOW:
Report Date Mar-11 Mar-12 Mar-13 Mar-14
Cash from Operating Activity 755.40 1,612.60 1,377.90 1,969.70
Cash from Investing Activity -884.80 -970.70 -1,436.90 -1,603.50
Cash from Financing Activity 44.50 389.10 -156.80 -24.20
Net Cash Flow -84.90 1,031.00 -215.80 342.00
DERIVED:
Adjusted Equity Shares in Cr 16.92 16.96 16.98 17.01
PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET